Related Experiment Video
Updated: Jul 14, 2026
09:09
A Modified Heterotopic Swine Hind Limb Transplant Model for Translational Vascularized Composite Allotransplantation (VCA) Research
Published on: October 14, 2013
Reduction in blood loss in total hip arthroplasty using topical Colgen
1East Surrey Hospital, Redhill, England.
The Journal of Arthroplasty
|September 1, 1989
Summary
Colgen, a nondenatured collagen, significantly reduced blood loss after hip replacement surgery. This hemostatic agent offers a safe method to minimize transfusions in uncemented total hip arthroplasty patients.
Area of Science:
- Orthopedic Surgery
- Biomaterials
- Hemostasis
Background:
- Uncemented total hip arthroplasty (THA) is associated with significant intraoperative and postoperative blood loss.
- Reducing blood loss is crucial to minimize the need for blood transfusions, which carry inherent risks.
Purpose of the Study:
- To evaluate the efficacy of Colgen, a nondenatured collagen hemostatic agent, in reducing blood loss following uncemented THA.
- To assess the safety and effectiveness of Colgen in minimizing blood transfusion requirements.
Main Methods:
- A randomized controlled trial was conducted with 76 patients undergoing uncemented THA.
- Colgen was applied topically in the surgical site for the intervention group (38 patients), while the control group (38 patients) received standard care.
- Blood loss was measured intraoperatively and calculated postoperatively using standard methods.
Main Results:
- No significant difference in intraoperative blood loss was observed between the Colgen and control groups.
- Postoperative visible and total calculated blood loss were significantly reduced in the Colgen group compared to controls (P < .05 and P < .01, respectively).
Conclusions:
- Topical application of Colgen effectively reduces postoperative blood loss after uncemented total hip arthroplasty.
- Colgen represents a valuable adjunct for minimizing blood loss and transfusion needs in THA surgery.
